#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	460	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1093	22.6	0	.	p	.	0	K29T	NONSYN	85	87	AAG	291	293	ACG	25;25;23	A;C;G	25;25;23	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	256	Chlamydophila_psittaci_16S	1507	118	92.37	Chlamydophila_psittaci_16S.l15.c17.ctg.1	121	25.8	0	.	n	.	0	A888G	SNP	888	888	A	7	7	G	4	G	4	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	256	Chlamydophila_psittaci_16S	1507	118	92.37	Chlamydophila_psittaci_16S.l15.c17.ctg.1	121	25.8	0	.	n	.	0	C897G	SNP	897	897	C	16	16	G	7	G	7	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	256	Chlamydophila_psittaci_16S	1507	118	92.37	Chlamydophila_psittaci_16S.l15.c17.ctg.1	121	25.8	0	.	n	.	0	T898C	SNP	898	898	T	17	17	C	7	C	7	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	256	Chlamydophila_psittaci_16S	1507	118	92.37	Chlamydophila_psittaci_16S.l15.c17.ctg.1	121	25.8	0	.	n	.	0	G906T	SNP	906	906	G	25	25	T	12	T	12	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	256	Chlamydophila_psittaci_16S	1507	118	92.37	Chlamydophila_psittaci_16S.l15.c17.ctg.1	121	25.8	0	.	n	.	0	G908A	SNP	908	908	G	27	27	A	13	A	13	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	256	Chlamydophila_psittaci_16S	1507	118	92.37	Chlamydophila_psittaci_16S.l15.c17.ctg.1	121	25.8	0	.	n	.	0	A918T	SNP	918	918	A	37	37	T	20	T	20	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	256	Chlamydophila_psittaci_16S	1507	118	92.37	Chlamydophila_psittaci_16S.l15.c17.ctg.1	121	25.8	0	.	n	.	0	A943G	SNP	943	943	A	62	62	G	48	G	48	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	256	Chlamydophila_psittaci_16S	1507	118	92.37	Chlamydophila_psittaci_16S.l15.c17.ctg.1	121	25.8	0	.	n	.	0	G991T	SNP	991	991	G	110	110	T	27	T	25	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	655	1652	Escherichia_coli_EF_Tu	1185	1185	99.58	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1651	51.4	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1391	1393	AGC	35;34;34	A,G;G;C	21,14;34;34	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	655	1652	Escherichia_coli_EF_Tu	1185	1185	99.58	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1651	51.4	0	HET	.	.	.	C954T	.	954	954	C	1165	1165	C	84	C,T	42,42	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	655	1652	Escherichia_coli_EF_Tu	1185	1185	99.58	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1651	51.4	0	HET	.	.	.	C216T	.	216	216	C	427	427	C	61	C,T	42,19	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	Escherichia_coli_EF_Tu.3003370.NC_000913.3.3470144_3471329.3532	1	1	655	1652	Escherichia_coli_EF_Tu	1185	160	95.62	Escherichia_coli_EF_Tu.l15.c17.ctg.2	198	4.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Enacyloxin IIa
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	608	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1829	17.8	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1575	1577	AAA	5;5;5	A;A;A	5;5;5	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	770	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l6.c30.ctg.1	1758	23.4	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1239	1241	GAA	29;30;29	G;A;A	29;30;29	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	148	H_NS	414	414	99.03	H_NS.l6.c30.ctg.1	638	11.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	104	G	84	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	107	T	86	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	121	G	119	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	114	C	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	108	C	108	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	111	T	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	117	C	116	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	99	C	99	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	88	A	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	85	A	85	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	82	A	82	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	79	T	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	79	C	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	70	C	70	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	69	A	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	65	G	65	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	64	C	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	76	T	75	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	97	G	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	108	G	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	110	T	107	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	115	T	115	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	106	G	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	93	C	92	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	89	A	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	50	C	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	46	C	46	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	6	A	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	6	A	6	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	10	G	10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	20	C	20	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	58	T	58	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	61	G	60	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	57	T	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	113	C	113	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	656	2204	Pasteurella_multocida_16S	1551	526	91.65	Pasteurella_multocida_16S.l15.c30.ctg.2	532	107.2	0	HET	.	.	.	C1040T	.	1040	1040	T	15	15	C	97	C,T	63,14	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	634	PmrB_1	1092	1092	99.27	PmrB_1.l15.c30.ctg.1	1506	22.4	0	.	p	.	0	H2R	NONSYN	4	6	CAT	213	215	CGT	15;15;14	C;G;T	15;14;14	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	634	PmrB_1	1092	1092	99.27	PmrB_1.l15.c30.ctg.1	1506	22.4	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1056	1058	GGC	22;22;22	G;G;C	22;22;22	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	908	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2032	23.9	0	.	p	.	0	R8S	NONSYN	22	24	AGA	192	194	AGC	13;13;15	A;G;C	13;13;15	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	908	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2032	23.9	0	.	p	.	0	I142L	NONSYN	424	426	ATA	594	596	CTA	21;21;21	C;T;A	21;21;19	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	908	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2032	23.9	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1113	1115	CAA	37;36;38	C;A;A	36;36;38	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	908	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2032	23.9	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1212	1214	GGT	21;21;20	G;G;T	21;21;20	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	908	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2032	23.9	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1782	1784	GTT	19;18;17	G;T;T	19;18;17	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	436	PmrE	1167	1167	96.92	PmrE.l15.c17.ctg.1	1316	16.9	0	.	p	.	0	A125E	NONSYN	373	375	GCA	481	483	GAA	25;25;24	G;A;A	25;25;24	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	436	PmrE	1167	1167	96.92	PmrE.l15.c17.ctg.1	1316	16.9	0	.	p	.	0	M185T	NONSYN	553	555	ATG	661	663	ACC	7;7;7	A;C;C	7;7;7	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	436	PmrE	1167	1167	96.92	PmrE.l15.c17.ctg.1	1316	16.9	0	.	p	.	0	S225T	NONSYN	673	675	TCC	781	783	ACT	10;10;9	A;C;T	10;10;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	436	PmrE	1167	1167	96.92	PmrE.l15.c17.ctg.1	1316	16.9	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1171	1173	ATC	11;10;10	A;T;C	11;9;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	480	PmrF	969	969	99.38	PmrF.l6.c30.ctg.1	1191	21.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
TEM_124.3000986.AY327540.0_858.1398	TEM_124.3000986.AY327540.0_858.1398	1	0	16	30	TEM_1+	858	172	100.0	TEM_1+.l6.c30.ctg.1	172	1.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-124;TEM-124 is an extended-spectrum beta-lactamase found in Morganella morganii.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1388	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3491	21.2	0	.	p	.	0	T85I	NONSYN	253	255	ACC	502	504	ATC	16;15;16	A;T;C	16;15;16	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1388	acrD	3114	3114	99.1	acrD.l6.c30.ctg.1	3491	21.2	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2215	2217	AAG	11;10;10	A;A;G	11;10;10	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	668	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1520	23.5	0	.	p	.	0	A22V	NONSYN	64	66	GCC	247	249	GTC	13;15;16	G;T;C	13;15;16	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	668	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1520	23.5	0	.	p	.	0	S269C	NONSYN	805	807	AGC	988	990	TGC	31;31;31	T;G;C	31;30;30	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1662	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3303	26.5	0	.	p	.	0	S46trunc	TRUNC	136	136	T	192	192	T	18	T	17	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1662	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3303	26.5	0	.	p	.	0	G148D	NONSYN	442	444	GGC	498	500	GAC	32;32;32	G;A;C	30;31;30	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1662	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3303	26.5	0	.	p	.	0	F240L	NONSYN	718	720	TTT	774	776	TTA	9;9;9	T;T;A	9;9;9	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1662	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3303	26.5	0	.	p	.	0	K599N	NONSYN	1795	1797	AAG	1851	1853	AAT	24;24;22	A;A;T	23;24;22	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1662	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3303	26.5	0	.	p	.	0	N637S	NONSYN	1909	1911	AAT	1965	1967	AGT	17;17;17	A;G;T	17;17;17	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1662	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3303	26.5	0	.	p	.	0	L770V	NONSYN	2308	2310	TTG	2364	2366	GTG	20;22;21	G;T;G	20;21;21	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	1662	acrF	3105	3105	98.78	acrF.l15.c17.ctg.1	3303	26.5	0	.	p	.	0	E955K	NONSYN	2863	2865	GAG	2919	2921	AAG	21;22;23	A;A;G	20;22;23	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	346	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1087	17.1	1	SNP	p	R45C	0	.	.	133	135	CGC	368	370	CGC	29;28;26	C;G;C	29;27;26	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	338	acrS	663	663	98.79	acrS.l15.c30.ctg.1	968	18.2	0	.	p	.	0	L34F	NONSYN	100	102	CTC	188	190	TTC	18;18;18	T;T;C	18;18;18	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	338	acrS	663	663	98.79	acrS.l15.c30.ctg.1	968	18.2	0	.	p	.	0	E122G	NONSYN	364	366	GAG	452	454	GGG	18;18;17	G;G;G	18;18;17	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	460	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1152	21.2	0	.	p	.	0	V136L	NONSYN	406	408	GTT	611	613	CTT	37;37;39	C;T;T	37;37;39	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1548	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3155	26.3	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2111	2113	GCA	33;33;34	G,A;C;A	32,1;33;33	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1548	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3155	26.3	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2372	2374	ACC	32;33;33	A;C;C	31;31;30	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1548	alaS	2631	2631	98.94	alaS.l15.c4.ctg.1	3155	26.3	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2681	2683	GCC	21;22;23	G;C;C	21;20;23	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	786	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2378	17.7	0	.	p	.	0	G37A	NONSYN	109	111	GGT	294	296	GCT	4;5;6	G;C;T	4;5;6	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	786	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2378	17.7	0	.	p	.	0	D77E	NONSYN	229	231	GAT	414	416	GAG	10;9;8	G;A;G	10;9;8	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	786	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2378	17.7	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	450	452	TGC	4;4;5	T;G;C	4;4;5	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	786	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2378	17.7	0	.	p	.	0	I150V	NONSYN	448	450	ATT	633	635	GTT	20;20;21	G;T;T	20;20;21	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	786	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2378	17.7	0	.	p	.	0	R200H	NONSYN	598	600	CGC	783	785	CAC	16;15;15	C;A;C	16;15;15	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	786	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2378	17.7	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1068	1070	ATG	34;34;32	A;T;G	34;34;32	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	786	arnA_1	1983	1983	98.29	arnA_1.l6.c30.ctg.1	2378	17.7	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2064	2066	CGC	16;15;17	C;G;C	16;15;17	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	336	bacA	822	822	98.54	bacA.l15.c4.ctg.1	931	17.3	0	.	p	.	0	S221T	NONSYN	661	663	AGC	768	770	ACC	10;10;8	A;C;C	10;10;7	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	336	bacA	822	822	98.54	bacA.l15.c4.ctg.1	931	17.3	0	.	p	.	0	P225S	NONSYN	673	675	CCG	780	782	TCG	8;10;9	T;C;G	8;10;9	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	539	288	baeR	723	723	97.65	baeR.l6.c4.ctg.1	989	15.4	0	.	p	.	0	S214F	NONSYN	640	642	TCT	833	835	TTT	4;4;4	T;T;T	4;4;4	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	670	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1490	22.6	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1200	1202	AAA	8;7;7	A;A;A	7;7;7	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	670	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1490	22.6	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1212	1214	GAG	9;9;9	G;A;G	8;8;9	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	670	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1490	22.6	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1218	1220	CAC	11;13;13	C;A;C	10;12;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	670	baeS	1404	1404	98.86	baeS.l15.c30.ctg.1	1490	22.6	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1272	1274	GAG	19;17;18	G;A;G	19;17;17	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	539	794	cpxA	1374	1374	98.76	cpxA.l15.c4.ctg.1	1992	21.4	0	.	p	.	0	A231T	NONSYN	691	693	GCG	1002	1004	ACG	27;27;27	A;C;G	27;27;27	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	474	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1034	24.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.;cpxR
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	394	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1327	15.8	0	.	p	.	0	T132I	NONSYN	394	396	ACA	566	568	ATA	21;21;20	A;T;A	21;21;20	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	544	emrA	1173	1173	98.38	emrA.l15.c30.ctg.1	1381	20.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	661	663	GTC	39;38;37	G;T;C	39;38;37	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	27	844	emrB	1539	1539	99.81	emrB.l6.c4.ctg.1	1957	22.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	604	emrD	1191	1191	98.57	emrD.l15.c4.ctg.1	1586	20.2	0	.	p	.	0	G209S	NONSYN	625	627	GGC	797	799	AGC	21;21;21	A;G;C	21;21;21	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	0	26	emrE_1	333	93	96.77	emrE_1.l6.c4.ctg.1	93	5.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	0	26	emrE_1	333	142	92.96	emrE_1.l6.c4.ctg.2	232	3.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	452	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1449	16.8	0	.	p	.	0	K176R	NONSYN	526	528	AAG	723	725	AGG	15;14;14	A;G;G	15;14;14	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	452	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1449	16.8	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1113	1115	GAC	11;11;10	G;A;C	11;11;10	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	334	emrR	531	531	100.0	emrR.l6.c4.ctg.1	982	18.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	722	emrY	1539	1539	99.81	emrY.l15.c30.ctg.1	1923	20.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	254	evgA	615	615	99.19	evgA.l15.c17.ctg.1	871	14.9	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	252	254	CTG	27;27;27	C;T;G,T	27;27;26,1	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	2511	97.81	evgS.l15.c4.ctg.1	2689	19.8	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	13	15	TTA	1;1;2	T;T;A	1;1;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	2511	97.81	evgS.l15.c4.ctg.1	2689	19.8	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	214	216	AAA	12;11;11	A;A;A	12;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	2511	97.81	evgS.l15.c4.ctg.1	2689	19.8	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	949	951	CAT	14;13;13	C;A;T	14;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	2511	97.81	evgS.l15.c4.ctg.1	2689	19.8	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	1003	1005	CAT	14;16;16	C;A;T	14;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	2511	97.81	evgS.l15.c4.ctg.1	2689	19.8	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1021	1023	AGA	14;14;14	A;G;A	14;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	2511	97.81	evgS.l15.c4.ctg.1	2689	19.8	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1036	1038	AAT	15;17;17	A;A;T	15;17;17	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	2511	97.81	evgS.l15.c4.ctg.1	2689	19.8	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1183	1185	TCC	12;11;11	T;C;C	12;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	2511	97.81	evgS.l15.c4.ctg.1	2689	19.8	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1348	1350	ATT	14;13;13	A;T;T	14;13;13	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	2511	97.81	evgS.l15.c4.ctg.1	2689	19.8	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1369	1371	GAT	11;11;11	G;A;T	11;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	2511	97.81	evgS.l15.c4.ctg.1	2689	19.8	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1483	1485	GTT	21;21;22	G;T;T	21;21;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	2511	97.81	evgS.l15.c4.ctg.1	2689	19.8	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1768	1770	CAC	17;18;18	C;A;C	17;18;18	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	659	96.81	evgS.l15.c4.ctg.2	659	16.3	0	.	p	.	0	L42V	NONSYN	124	126	CTA	5	7	GTA	5;5;5	G;T;A	5;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	659	96.81	evgS.l15.c4.ctg.2	659	16.3	0	.	p	.	0	A93T	NONSYN	277	279	GCG	158	160	ACG	19;17;20	A;C;G	19;17;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	659	96.81	evgS.l15.c4.ctg.2	659	16.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	221	223	GAA	22;23;23	G;A;A	22;23;23	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	659	96.81	evgS.l15.c4.ctg.2	659	16.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	260	262	GCT	20;20;20	G;C;T	20;20;20	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	659	96.81	evgS.l15.c4.ctg.2	659	16.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	278	280	GAT	10;10;10	G;A;T	10;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	659	96.81	evgS.l15.c4.ctg.2	659	16.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	365	367	TCA	13;12;12	T;C;A	13;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	659	96.81	evgS.l15.c4.ctg.2	659	16.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	494	496	CAG	20;19;19	C;A;G	20;19;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	659	96.81	evgS.l15.c4.ctg.2	659	16.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	632	634	GTT	10;10;10	G;T;T	10;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	120	99.17	evgS.l15.c4.ctg.3	330	12.8	0	.	p	.	0	T38I	NONSYN	112	114	ACA	322	324	ATA	9;9;6	A;T;A	9;9;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1338	evgS	3594	309	97.41	evgS.l15.c4.ctg.4	320	10.5	0	.	p	.	0	N303D	NONSYN	907	909	AAT	143	145	GAT	7;7;7	G;A;T	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	416	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1211	18.2	1	SNP	p	P64A	0	.	.	190	192	CCA	353	355	CCA	40;39;38	C;C;A	40;38;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	416	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1211	18.2	1	SNP	p	P64L	0	.	.	190	192	CCA	353	355	CCA	40;39;38	C;C;A	40;38;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	416	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1211	18.2	1	SNP	p	P64S	0	.	.	190	192	CCA	353	355	CCA	40;39;38	C;C;A	40;38;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	416	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1211	18.2	1	SNP	p	P64H	0	.	.	190	192	CCA	353	355	CCA	40;39;38	C;C;A	40;38;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	416	folP_1	849	849	99.29	folP_1.l15.c17.ctg.1	1211	18.2	1	SNP	p	P64R	0	.	.	190	192	CCA	353	355	CCA	40;39;38	C;C;A	40;38;37	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	318	gadE	528	528	100.0	gadE.l15.c30.ctg.1	954	17.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	102	gadW	729	168	96.43	gadW.l15.c17.ctg.1	169	11.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	102	gadW	729	137	93.43	gadW.l15.c17.ctg.2	137	5.1	0	.	p	.	0	E54D	NONSYN	160	162	GAA	8	10	GAT	5;7;7	G;A;T	5;7;7	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	102	gadW	729	137	93.43	gadW.l15.c17.ctg.2	137	5.1	0	.	p	.	0	I88M	NONSYN	262	264	ATA	110	112	ATG	4;4;4	A;T;G	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	102	gadW	729	137	93.43	gadW.l15.c17.ctg.2	137	5.1	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	113	115	CCG	4;4;4	C;C;G	4;4;4	.	gadW;GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	328	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1020	17.0	0	.	p	.	0	F53L	NONSYN	157	159	TTC	287	289	TTA	23;21;20	T;T;A	23;21;20	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	328	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1020	17.0	0	.	p	.	0	V79I	NONSYN	235	237	GTT	365	367	ATT	12;11;11	A;T;T	12;11;11	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	328	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1020	17.0	0	.	p	.	0	R246G	NONSYN	736	738	AGA	866	868	GGA	9;9;10	G;G;A	9;9;10	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	328	gadX	825	825	97.94	gadX.l6.c30.ctg.1	1020	17.0	0	.	p	.	0	S248P	NONSYN	742	744	TCG	872	874	CCG	10;10;11	C;C;G	10;10;11	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1512	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3063	26.3	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2224	2226	GAA	36;36;36	G;A;A	36;36;36	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1512	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3063	26.3	1	SNP	p	S83I	0	.	.	247	249	TCG	439	441	TCG	31;30;32	T;C;G	30;29;32	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1512	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3063	26.3	1	SNP	p	S83W	0	.	.	247	249	TCG	439	441	TCG	31;30;32	T;C;G	30;29;32	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1512	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3063	26.3	1	SNP	p	S83L	0	.	.	247	249	TCG	439	441	TCG	31;30;32	T;C;G	30;29;32	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1512	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3063	26.3	1	SNP	p	D87N	0	.	.	259	261	GAC	451	453	GAC	31;30;30	G;A;C	30;28;30	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1512	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3063	26.3	1	SNP	p	D87V	0	.	.	259	261	GAC	451	453	GAC	31;30;30	G;A;C	30;28;30	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1512	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3063	26.3	1	SNP	p	D87Y	0	.	.	259	261	GAC	451	453	GAC	31;30;30	G;A;C	30;28;30	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1512	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3063	26.3	1	SNP	p	D87H	0	.	.	259	261	GAC	451	453	GAC	31;30;30	G;A;C	30;28;30	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1512	gyrA_7	2628	2628	98.71	gyrA_7.l15.c30.ctg.1	3063	26.3	1	SNP	p	D87G	0	.	.	259	261	GAC	451	453	GAC	31;30;30	G;A;C	30;28;30	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1284	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2965	23.1	1	SNP	p	R136G	0	.	.	406	408	CGC	692	694	CGC	22;21;19	C;G;C	22;21;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1284	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2965	23.1	1	SNP	p	R136I	0	.	.	406	408	CGC	692	694	CGC	22;21;19	C;G;C	22;21;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1284	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2965	23.1	1	SNP	p	R136H	0	.	.	406	408	CGC	692	694	CGC	22;21;19	C;G;C	22;21;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1284	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2965	23.1	1	SNP	p	R136C	0	.	.	406	408	CGC	692	694	CGC	22;21;19	C;G;C	22;21;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1284	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2965	23.1	1	SNP	p	R136S	0	.	.	406	408	CGC	692	694	CGC	22;21;19	C;G;C	22;21;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1284	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2965	23.1	1	SNP	p	R136E	0	.	.	406	408	CGC	692	694	CGC	22;21;19	C;G;C	22;21;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1284	gyrB_1	2415	2415	99.13	gyrB_1.l6.c30.ctg.1	2965	23.1	1	SNP	p	R136L	0	.	.	406	408	CGC	692	694	CGC	22;21;19	C;G;C	22;21;19	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	531	268	kdpE	678	676	98.08	kdpE.l15.c30.ctg.1	798	16.2	0	.	p	.	0	A72P	NONSYN	214	216	GCG	336	338	CCG	20;20;24	C;C;G	20;20;24	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	531	268	kdpE	678	676	98.08	kdpE.l15.c30.ctg.1	798	16.2	0	.	p	.	0	T123A	NONSYN	367	369	ACC	489	491	GCC	13;13;12	G;C;C	13;12;12	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	520	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1293	21.6	0	.	p	.	0	P9S	NONSYN	25	27	CCA	194	196	TCA	18;17;16	T;C;A	18;17;16	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	188	marA	384	384	99.74	marA.l15.c4.ctg.1	763	13.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	545	547	AGC	14;12;9	A;G;C	14;12;9	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	647	649	CAT	1;1;1	C;A;T	1;1;1	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	V45E	0	.	.	133	135	GTG	371	373	GTG	16;17;17	G;T;G	16;17;17	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	I49S	0	.	.	145	147	ATC	383	385	ATC	14;13;12	A;T;C	14;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	A70T	0	.	.	208	210	GCA	446	448	GCA	7;7;7	G;C;A	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	R73S	0	.	.	217	219	CGT	455	457	CGT	7;7;6	C;G;T	7;7;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	R73C	0	.	.	217	219	CGT	455	457	CGT	7;7;6	C;G;T	7;7;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	R77C	0	.	.	229	231	CGC	467	469	CGC	6;6;6	C;G;C	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	R77L	0	.	.	229	231	CGC	467	469	CGC	6;6;6	C;G;C	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	L78M	0	.	.	232	234	CTG	470	472	CTG	7;7;6	C;T;G	7;7;6	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	R94S	0	.	.	280	282	CGC	518	520	CGC	12;12;12	C;G;C,T	12;12;11,1	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	R94H	0	.	.	280	282	CGC	518	520	CGC	12;12;12	C;G;C,T	12;12;11,1	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	531	94	marR	435	434	97.7	marR.l6.c30.ctg.1	672	7.3	1	SNP	p	V96E	0	.	.	286	288	GTA	524	526	GTA	12;12;12	G;T;A	12;12;12	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1218	96.72	mdfA.l6.c4.ctg.1	1441	13.8	0	.	p	.	0	S7F	NONSYN	19	21	TCC	4	6	TTC	3;3;3	T;T;C	1;1;1	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1218	96.72	mdfA.l6.c4.ctg.1	1441	13.8	0	.	p	.	0	R36I	NONSYN	106	108	AGG	91	93	ATC	6;6;6	A;T;C	6;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1218	96.72	mdfA.l6.c4.ctg.1	1441	13.8	0	.	p	.	0	E42A	NONSYN	124	126	GAA	109	111	GCC	5;5;5	G;C;C	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1218	96.72	mdfA.l6.c4.ctg.1	1441	13.8	0	.	p	.	0	N43V	NONSYN	127	129	AAT	112	114	GTG	5;5;5	G;T;G	5;5;5	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1218	96.72	mdfA.l6.c4.ctg.1	1441	13.8	0	.	p	.	0	E52D	NONSYN	154	156	GAG	139	141	GAT	8;9;9	G;A;T	8;9;9	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1218	96.72	mdfA.l6.c4.ctg.1	1441	13.8	0	.	p	.	0	N59T	NONSYN	175	177	AAC	160	162	ACC	8;8;8	A;C;C	8;8;8	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1218	96.72	mdfA.l6.c4.ctg.1	1441	13.8	0	.	p	.	0	I68L	NONSYN	202	204	ATA	187	189	TTA	6;6;6	T;T;A	6;6;6	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1218	96.72	mdfA.l6.c4.ctg.1	1441	13.8	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	328	330	CAG	20;20;20	C;A;G	20;19;20	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1218	96.72	mdfA.l6.c4.ctg.1	1441	13.8	0	.	p	.	0	D128A	NONSYN	382	384	GAC	367	369	GCC	17;17;17	G;C;C	17;17;17	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1218	96.72	mdfA.l6.c4.ctg.1	1441	13.8	0	.	p	.	0	S163A	NONSYN	487	489	TCG	472	474	GCG	12;12;11	G;C;G	12;11;11	.	Multidrug translocase MdfA;mdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	382	mdfA	1233	1218	96.72	mdfA.l6.c4.ctg.1	1441	13.8	0	.	p	.	0	G224fs	FSHIFT	670	670	G	655	655	G	10	G	6	.	Multidrug translocase MdfA;mdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	372	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1434	13.5	0	.	p	.	0	V12trunc	TRUNC	34	34	G	41	41	G	12	G	12	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	372	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1434	13.5	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	98	100	CAG	9;9;9	C;A;G	9;9;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	372	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1434	13.5	0	.	p	.	0	T83I	NONSYN	247	249	ACC	248	250	ATC	6;6;6	A;T;C	6;6;6	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	372	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1434	13.5	0	.	p	.	0	I99M	NONSYN	295	297	ATA	296	298	ATG	8;8;8	A;T;G	8;8;8	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	372	mdtA	1248	1248	97.44	mdtA.l15.c17.ctg.1	1434	13.5	0	.	p	.	0	A130T	NONSYN	388	390	GCC	389	391	ACC	7;8;9	A;C;C	7;8;9	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1562	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3452	24.0	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1957	1959	ACC	34;34;34	A;C;C	33;34;34	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1562	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3452	24.0	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2350	2352	CAA	19;20;20	C;A;A	19;20;20	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1562	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3452	24.0	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2518	2520	ATT	13;13;13	A;T;T	13;13;13	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1562	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3452	24.0	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2602	2604	GTT	19;19;19	G;T;T	19;18;18	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1562	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3452	24.0	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2710	2712	GAG	24;23;25	G;A;G	24;23;25	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1562	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3452	24.0	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2938	2940	ATG	8;9;9	A;T;G	8;8;9	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1562	mdtB	3123	3123	98.94	mdtB.l15.c4.ctg.1	3452	24.0	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3073	3075	GAT	18;18;18	G;A;T	18;18;18	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1380	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3292	22.0	0	.	p	.	0	I46M	NONSYN	136	138	ATC	328	330	ATG	13;13;13	A;T;G	13;13;13	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1380	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3292	22.0	0	.	p	.	0	V208I	NONSYN	622	624	GTC	814	816	ATC	21;23;23	A;T;C	21;22;23	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	1380	mdtC	3078	3078	98.7	mdtC.l15.c4.ctg.1	3292	22.0	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3130	3132	CAC	5;5;6	C;A;C	5;5;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	630	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1837	18.4	0	.	p	.	0	D3E	NONSYN	7	9	GAT	187	189	GAA	8;6;6	G;A;A	7;6;6	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	630	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1837	18.4	0	.	p	.	0	T226A	NONSYN	676	678	ACG	856	858	GCG	9;12;13	G;C;G	9;12;13	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	630	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1837	18.4	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1198	1200	ATC	34;34;35	A;T;C	34;33;35	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	630	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1837	18.4	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1501	1503	TTT	27;27;27	T;T;T	27;27;27	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	772	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1610	25.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1700	mdtF	3114	3114	98.52	mdtF.l6.c30.ctg.1	3584	25.3	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1120	1122	ACC	24;24;23	A;C,A;C	24;21,1;23	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1700	mdtF	3114	3114	98.52	mdtF.l6.c30.ctg.1	3584	25.3	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2362	2364	GAC	33;33;32	G;A;C	33;33;32	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	492	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1473	15.1	0	.	p	.	0	V200I	NONSYN	598	600	GTC	639	641	ATC	19;18;19	A;T;C	19;18;19	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	492	mdtG	1227	174	99.43	mdtG.l15.c4.ctg.2	335	8.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	5	7	GGA	1;1;2	G;G;A	1;1;2	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	436	mdtH	1209	1209	98.1	mdtH.l6.c4.ctg.1	1512	15.2	0	.	p	.	0	G134C	NONSYN	400	402	GGT	580	582	TGT	16;16;16	T;G;T	16;16;16	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	436	mdtH	1209	1209	98.1	mdtH.l6.c4.ctg.1	1512	15.2	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1150	1152	TTG	17;16;17	T;T;G	17;16;17	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	436	mdtH	1209	1209	98.1	mdtH.l6.c4.ctg.1	1512	15.2	0	.	p	.	0	L359Q	NONSYN	1075	1077	CTG	1255	1257	CAG	10;11;11	C;A;G	8;11;11	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	436	mdtH	1209	1209	98.1	mdtH.l6.c4.ctg.1	1512	15.2	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1360	1362	ACG	9;10;10	A;C;G	9;10;10	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	662	mdtL	1176	1176	98.47	mdtL.l15.c30.ctg.1	1642	21.6	0	.	p	.	0	A185S	NONSYN	553	555	GCC	759	761	TCC	10;10;10	T;C;C	9;10;9	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	424	mdtN	1032	1032	98.16	mdtN.l6.c30.ctg.1	1448	15.3	0	.	p	.	0	V119I	NONSYN	355	357	GTT	542	544	ATT	17;16;17	A;T;T	17;16;17	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	940	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2473	20.3	0	.	p	.	0	V11M	NONSYN	31	33	GTG	170	172	ATG	16;17;17	A;T;G	16;17;17	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	940	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2473	20.3	0	.	p	.	0	T33I	NONSYN	97	99	ACC	236	238	ATC	19;19;20	A;T;C	19;19;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	940	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2473	20.3	0	.	p	.	0	C116R	NONSYN	346	348	TGC	485	487	CGC	33;33;32	C;G;C	33;33;32	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	940	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2473	20.3	0	.	p	.	0	N238S	NONSYN	712	714	AAC	851	853	AGC	22;20;21	A;G;C	22;19;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	940	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2473	20.3	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1052	1054	GTG	18;17;17	G;T;G	18;15;16	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	940	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2473	20.3	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1115	1117	AAC	12;14;14	A;A;C	11;12;13	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	940	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2473	20.3	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1160	1162	GTC	14;15;15	G;T;C	13;15;15	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	940	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2473	20.3	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1190	1192	ATA	18;18;18	A;T;A	17;17;18	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	940	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2473	20.3	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1298	1300	TCT	15;15;15	T;C;T	15;15;15	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	940	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2473	20.3	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1685	1687	GCG	20;21;21	G;C;G	20;21;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	940	mdtO	2052	2052	98.15	mdtO.l6.c30.ctg.1	2473	20.3	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1898	1900	ATC	20;20;20	A;T;C	20;19;20	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	652	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1719	20.0	0	.	p	.	0	S129A	NONSYN	385	387	TCA	468	470	GCG	24;24;25	G;C;G,T	24;24;24,1	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	652	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1719	20.0	0	.	p	.	0	A187T	NONSYN	559	561	GCC	642	644	ACC	21;21;21	A;C;C	21;21;21	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	652	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1719	20.0	0	.	p	.	0	H211R	NONSYN	631	633	CAC	714	716	CGC	23;24;26	C;G;C	23;24;26	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	652	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1719	20.0	0	.	p	.	0	V250A	NONSYN	748	750	GTT	831	833	GCT	19;21;20	G;C;T	19;21;20	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	652	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1719	20.0	0	.	p	.	0	R278K	NONSYN	832	834	AGA	915	917	AAA	15;15;13	A;A;A	15;15;13	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	652	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1719	20.0	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	933	935	CGA	16;16;16	C;G;A	16;16;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	652	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1719	20.0	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1098	1100	GCC	13;12;12	G;C;C	13;12;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	652	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1719	20.0	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1110	1112	GAT	16;16;16	G;A;T	16;16;16	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	652	mdtP	1467	1467	97.96	mdtP.l6.c30.ctg.1	1719	20.0	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1527	1529	GCT	7;7;7	G;C;T	7;7;7	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1364	mfd	3447	3447	99.16	mfd.l6.c17.ctg.1	3807	19.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1463	1465	AAG	22;21;21	A;A;G	22;21;21	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1364	mfd	3447	3447	99.16	mfd.l6.c17.ctg.1	3807	19.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2540	2542	CTG	23;23;23	C;T;G	23;23;23	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	94	mgrB	144	144	100.0	mgrB.l15.c30.ctg.2	161	16.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	916	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	2035	24.0	0	.	p	.	0	S278N	NONSYN	832	834	AGC	968	970	AAC	17;18;18	A;A;C	17;18;18	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	916	msbA	1749	1749	98.68	msbA.l6.c4.ctg.1	2035	24.0	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1514	1516	ATA	33;34;34	A;T;A	33;34;34	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	720	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1640	23.6	0	.	p	.	0	A343V	NONSYN	1027	1029	GCG	1216	1218	GTG	20;21;21	G;T;G	20;21;21	.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	720	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1640	23.6	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1294	1296	GAT	32;32;31	G;A;T	32;31;31	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	539	720	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1640	23.6	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1297	1299	CTG	31;31;31	C;T;G	31;31;31	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	268	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	887	15.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	122	124	TGT	5;5;5	T;G;T	5;5;5	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	268	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	887	15.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	392	394	ACC	14;15;16	A;C;C	14;15;16	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	268	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	887	15.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	602	604	GAC	14;14;15	G;A;C	14;14;15	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	268	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	887	15.0	1	SNP	p	R15C	0	.	.	43	45	CGC	86	88	CGC	23;22;22	C;G;C	23;22;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	268	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	887	15.0	1	SNP	p	S33R	0	.	.	97	99	AGC	140	142	AGC	7;7;7	A;G;C	7;7;7	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	268	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	887	15.0	1	SNP	p	G131D	0	.	.	391	393	GGC	434	436	GGC	20;17;17	G;G;C	19;17;16	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	268	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	887	15.0	1	SNP	p	R203C	0	.	.	607	609	CGT	650	652	CGT	15;14;15	C;G;T	15;14;15	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	268	nfsA	723	723	99.03	nfsA.l6.c30.ctg.1	887	15.0	1	SNP	p	R203L	0	.	.	607	609	CGT	650	652	CGT	15;14;15	C;G;T	15;14;15	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	578	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1326	22.5	1	SNP	p	G141E	0	.	.	421	423	GGT	605	607	GGT	28;30;30	G;G;T	28;30;30	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	578	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1326	22.5	1	SNP	p	G141D	0	.	.	421	423	GGT	605	607	GGT	28;30;30	G;G;T	28;30;30	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	578	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1326	22.5	1	SNP	p	R154A	0	.	.	460	462	CGT	644	646	CGT	34;35;35	C;G;T	34;35;35	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	27	578	ompF	1089	1089	100.0	ompF.l15.c4.ctg.1	1326	22.5	1	SNP	p	R154D	0	.	.	460	462	CGT	644	646	CGT	34;35;35	C;G;T	34;35;35	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1246	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2662	25.1	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1868	1870	TCG	37;37;38	T;C;G	37;36;38	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1246	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2662	25.1	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2483	2485	AAC	20;20;20	A;A;C	20;20;20	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1246	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2662	25.1	1	SNP	p	A85T	0	.	.	253	255	GCG	497	499	GCG	33;33;33	G;C;G	27;28;32	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1246	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2662	25.1	1	SNP	p	D111H	0	.	.	331	333	GAT	575	577	GAT	24;24;22	G;A;T	24;24;22	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1246	parC_2	2259	2259	99.29	parC_2.l15.c4.ctg.1	2662	25.1	1	SNP	p	S129P	0	.	.	385	387	TCC	629	631	TCC	24;24;25	T;C;C	23;24;24	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	736	parE_1	1893	1743	97.48	parE_1.l15.c30.ctg.1	1969	18.2	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1276	1278	GAT	30;30;30	G;A;T	29;29;30	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	3	736	parE_1	1893	145	98.62	parE_1.l15.c30.ctg.2	212	11.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	728	patA	1380	1380	99.86	patA.l15.c4.ctg.1	1841	21.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1290	1292	GAT	19;19;19	G;A;T	19;19;19	.	patA;PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2598	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	31.1	1	SNP	p	V146F	0	.	.	436	438	GTT	619	621	GTT	26;25;24	G;T;T	26;25;24	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2598	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	31.1	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1720	1722	CAG	34;34;32	C;A;G	34;34;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2598	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	31.1	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1720	1722	CAG	34;34;32	C;A;G	34;34;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2598	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	31.1	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1759	1761	CAC	22;22;22	C;A;C	21;20;22	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2598	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	31.1	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1768	1770	CGT	19;20;20	C;G;T	18;19;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2598	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	31.1	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1768	1770	CGT	19;20;20	C;G;T	18;19;20	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2598	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	31.1	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1774	1776	TCC	22;22;22	T;C;C	21;21;21	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2598	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	31.1	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1780	1782	CTC	22;23;23	C;T;C	22;23;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2598	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	31.1	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1870	1872	ACC	34;33;34	A;C;C	34;33;34	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2598	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	31.1	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1873	1875	CCT	35;33;33	C;C;T	35;33;33	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2598	rpoB	4029	4029	99.03	rpoB.l15.c30.ctg.1	4461	31.1	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2242	2244	CGT	53;55;54	C;G;T	52;54;52	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	.	n	.	0	A226G	SNP	226	226	A	368	368	G	219	G	218	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	1	SNP	n	A794T	0	.	.	794	794	A	936	936	A	188	A	185	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	1	SNP	n	A794G	0	.	.	794	794	A	936	936	A	188	A	185	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	1	SNP	n	G926C	0	.	.	926	926	G	1068	1068	G	192	G	191	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	1	SNP	n	G926A	0	.	.	926	926	G	1068	1068	G	192	G	191	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	1	SNP	n	G926T	0	.	.	926	926	G	1068	1068	G	192	G	191	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	1	SNP	n	A1519C	0	.	.	1519	1519	A	1661	1661	A	151	A,G	150,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	1	SNP	n	A1519G	0	.	.	1519	1519	A	1661	1661	A	151	A,G	150,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	1	SNP	n	A1519T	0	.	.	1519	1519	A	1661	1661	A	151	A,G	150,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	C183T	.	183	183	C	325	325	C	165	C,T	116,49	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	A250T	.	250	250	A	392	392	A	207	A,T	150,57	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	T90C	.	90	90	T	232	232	T	172	T,C	132,36	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	G474A	.	474	474	G	616	616	G	205	G,A	158,46	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	A253T	.	253	253	A	395	395	A	208	A,T	150,57	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	C719T	.	719	719	C	861	861	C	150	C,T	87,62	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	C1038T	.	1038	1038	C	1180	1180	C	185	C,T	143,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	C194T	.	194	194	C	336	336	C	188	C,T	152,35	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	G1002A	.	1002	1002	G	1144	1144	G	176	G,A	130,46	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	G1006C	.	1006	1006	G	1148	1148	G	179	G,C	132,46	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	A79G	.	79	79	A	221	221	A	180	A,G	139,39	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	T273A	.	273	273	T	415	415	T	195	T,A	140,49	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	6566	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1698	193.0	0	HET	.	.	.	T1010C	.	1010	1010	T	1152	1152	T	181	T,C	136,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	340	soxR	465	465	100.0	soxR.l6.c4.ctg.1	809	22.3	1	SNP	p	R20H	0	.	.	58	60	CGC	218	220	CGC	32;32;31	C;G;C	32;32;31	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	340	soxR	465	465	100.0	soxR.l6.c4.ctg.1	809	22.3	1	SNP	p	G121D	0	.	.	361	363	GGT	521	523	GGT	36;37;37	G;G;T	35;36;36	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	230	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	699	17.2	1	SNP	p	A12S	0	.	.	34	36	GCA	229	231	GCA	25;25;24	G;C;A	25;25;24	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	822	tolC	1488	1488	98.72	tolC.l6.c4.ctg.1	1879	23.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
